Danisco Fails To Prove Novozymes Ethanol IP Invalid

Law360, New York (October 26, 2011, 5:47 PM EDT) -- A Wisconsin federal jury on Tuesday ruled that biotechnology company Danisco AS had failed to prove a patent invalid in an infringement suit brought by rival Novozymes AS over a variant of the enzyme alpha amylase, which is used to make ethanol.

The jury also ruled that Novozymes failed to prove patent infringement relating to a group of Danisco’s so-called whole broth products, in the dispute over U.S. Patent Number 7,713,723, the verdict said.

Danisco had argued that the '723 patent was invalid for lack of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.